Clinical trial
Combination Chemotherapy in Treating Patients With Advanced Cancer of the…
NCT00002955 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00002955 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas |
| Official title | Modulation of 5-Fluorouracil With Trimetrexate and Leucovorin in Advanced Pancreatic Cancer |
| Lead sponsor | University of Southern California, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug |
| Interventions | fluorouracil, leucovorin calcium, trimetrexate glucuronate |
| Enrollment | 21 |
| Start date | Aug 1, 1995 |
| Primary completion | May 1, 2000 |
| Completion | Jun 1, 2006 |
| First posted | Aug 12, 2004 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: